Skip to content
AZBio Logo
  • Members
    • AZBio Member Directory
      • Member Login
    • Join AZBio
    • Support AZBio
    • Save with AZBio Purchasing Power
  • AZBio News
    • Voice of the Patient
    • Resources for Media
      • 3rd Party Content
  • Events
    • 2026 State Bio Friends Reception
    • AZBio Day at The Capitol
    • Arizona Bioscience Week 2026
      • Looking Back at AZBW 2025
      • Looking Back at AZBW 2024
    • AZBio Awards 2026
    • White Hat 2026
  • Advocacy
    • AZBio Legislative Watch List for 2026
    • Request to Speak Instructions
    • AZBio Public Policy Principles
    • Arizona Congressional Delegation
    • 2026 Congressional Calendar
  • Resources
    • AZBioPEERS
    • AZBio PEERS Mentoring Program
    • Cost Saving Programs
    • Core Facilities
    • Arizona Life Science Infrastructure
    • Clinical Trials in Arizona
    • AZBio Career Center
    • Arizona BioMap
  • About AZBio
    • What We Do
    • AZBio Board of Directors
    • AZBio Staff
    • Arizona Bioindustry Fact Sheet
    • AZBio History
  • Menu

Category Archives: AZBio News

IMS Health Goes Public – IPO Raises $1.3 Billion

Posted on Sun/6/AprilSun/10/June by AZBio

The IMS Health Holdings (NYSE:IMS) IPO represents the second-biggest IPO so far this year in the U.S.

IMS Heath’s IMS One portfolio of products includes 360 Vantage|IMS Health (Chandler, AZ).  360 Vantage was acquired by IMS Heath in May of 2013.

Continue reading→

Phoenix moves closer to developing Arizona Biomedical Corridor near Mayo Clinic

Posted on Fri/4/AprilSun/10/June by AZBio
Apr 3, 2014, 3:52pm MST

The city of Phoenix is a step closer to developing the Arizona Biomedical Corridor near Mayo Clinic’s hospital in north Phoenix. Hear Mayo Clinic Arizona CEO Wyatt Decker talk about new corridor. 

Continue reading→

Ventana Signs Companion Diagnostics Agreement

Posted on Thu/3/AprilThu/3/April by AZBio

Ventana signs companion diagnostic agreement with international biotech for antibody drug conjugate programContinue reading→

Next Steps Announced in Advancing the ‘Arizona Biomedical Corridor’

Posted on Thu/3/AprilThu/3/April by AZBio

Mayor Stanton and the Phoenix City Council Take Next Steps to Advance ‘Arizona Biomedical Corridor’

  • Authorize $180 Million in Revenue Bonds to Finance  Mayo Clinic’s Cutting-Edge Cancer Therapy Center
  • Renew Agreement with ASU, Mayo Clinic to Develop Corridor
  • State Land Dept. Will Auction Corridor Land by Year’s End  


Continue reading→

UA Launches $1 Billion Fundraising Campaign

Posted on Thu/3/AprilThu/3/April by AZBio

UA to Kick Off the Largest Campaign in its History on April 11

By University Relations – Communications, April 2, 2014Continue reading→

Graduates Advance Medical Technology at the UA

Posted on Thu/3/AprilThu/3/April by AZBio

A PhD Less Ordinary

By Daniel Stolte, University Relations – Communications | April 2, 2014Continue reading→

Biodesign Team using tobacco to thwart West Nile virus

Posted on Sat/29/MarchSat/29/March by AZBio

An international research group, led by Arizona State University professor Qiang “Shawn” Chen, has developed a new generation of potentially safer and more cost-effective therapeutics against West Nile virus and other pathogens.Continue reading→

BIO Announces Kay Holcombe to Join as Senior Vice President, Science Policy

Posted on Fri/28/MarchFri/28/March by AZBio
WASHINGTON — Today, the Biotechnology Industry Organization (BIO) announced that Kay Holcombe will be joining staff as Senior Vice President, Science Policy.Continue reading→

Cord Blood Registry’s Newborn Possibilities Program

Posted on Thu/27/MarchThu/27/March by AZBio

25% of all the stem cell units released for use by CBR have been collected under their free access initiativeContinue reading→

TGen and Scottsdale Healthcare cancer expert Dr. Von Hoff receives Hope Funds award

Posted on Thu/27/MarchThu/27/March by AZBio

Dr. Daniel D. Von Hoff, who has been instrumental in developing numerous new cancer treatments, is among this year’s recipients of the Award of Excellence from the Hope Funds for Cancer Research.Continue reading→

Post navigation

« Previous 1 … 320 321 322 323 324 325 326 327 328 329 330 … 414 Next »

Blog Categories

Upcoming Events

  • Biotech Showcase 2026
            Jan 12, 2026 - San Francisco
  • RESI at JPM
            Jan 12, 2026 - San Francisco
  • BIO Partnering at JPM Week
            Jan 12, 2026 -
  • AZBio 2026 Kickoff at Clayco
            Jan 22, 2026 - Phoenix
  • AZBioPEERS: The Buzz at JPM 2026
            Jan 27, 2026 -
  • LSWC Best Workforce Strategies Roundtable: Building the Life Sciences Workforce of the Future
            Jan 30, 2026 -
  • OBBB - New Rules for Charitable Giving
            Feb 3, 2026 -
  • AZBio Day at The Capitol
            Feb 18, 2026 - Phoenix
  • 2026 Flinn Bio Capital Conference
            Mar 5, 2026 - Phoenix
  • 2026 Flinn Foundation Bio Capital Conference
            Mar 5, 2026 - Phoenix
  • Children's Health Advocacy Day 2026
            Mar 23, 2026 - Phoenix
  • IdeaFunding 2026
            Mar 26, 2026 - TUCSON
  • Arizona Tech Week - April 6-12
            Apr 6, 2026 -
  • AZAdvances Health Innovation Showcase - AZTECH WEEK
            Apr 7, 2026 - Phoenix
  • World Parkinson Conference - WPC 2026 Phoenix
            May 24, 2026 - Phoenix
  • BIO International Convention
            Jun 22, 2026 - San Diego
  • Arizona Bioscience Week
            Oct 5, 2026 -
  • 2026 AZBio Awards
            Oct 7, 2026 - Phoenix
  • all events

Blog Archive

  • Click the image for the latest news about AZBio Members
  • Click the image to learn more about AZBio Membership
  • Click the image to learn more
  • Click the image to enter the AZBio Career Center 
  • Click the image to learn more
  • Click the image to learn more
  • Click the logo to learn more
  • Click the logo to learn more
  • Patients are why we do what we do. Click the image to listen to their stories.

Disclaimer
Imprint
Cookie Policy (CA)
Privacy Policy (CA)

Copyright 2026 | Arizona Bioindustry Association, Inc.
A SiteOrigin Theme
Manage Cookie Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}
Manage Cookie Consent
We use cookies to optimize our website and our service.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}